ALK anticipates deficit despite record-quarter: "We decide if we generate profit"

Danish allergy group ALK recently presented the best Q1 interim report in the company's history. However, the CEO anticipates red numbers in the annual report as ALK continues to invest in the future.

Photo: /Ritzau Scanpix/Niels Ahlmann Olesen

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles